| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d0c553bfb9eb3ed4d5e6f934cf395b95
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6add5114afb1ae83acc210e2bbd4be37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5370940f958fcb1b2f3ffcfe7e8afa02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5de7a7b1b0f2adadd34270a8b11e698a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b0ec2a1634e91089fa6889ba07f200b2 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-06078
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D281-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-065
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 |
| filingDate |
2003-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b29965d02b33e3124f5756a77c4c4bbd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b2c542e53768b424edb30fbfc5e0611
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16cc979958428d046ab7de67da04717c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ce2cc2cf69dd8fb9cbe0ea45464f028
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25e675398e7492b3e3fafae479882184 |
| publicationDate |
2005-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2005222120-A1 |
| titleOfInvention |
Peptides derivatives comprising thiazepine group for the treatment of hyperlipidermic conditions |
| abstract |
The present invention relates to compounds of formula (I): (wherein variable groups are as defined within) pharmaceutically acceptable salts, solvates, solvates of such salts and prodrugs thereof and their use as ileal bile acid transport (IBAT) inhibitors for the treatment of hyperlipidaemia. Process for their manufacture and pharmaceutical compositions containing them are also described. |
| priorityDate |
2002-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |